首页 产品目录 分子砌块 按反应类型 1,2,4-三唑 2-((4R,7S,10S,13S,19S,22S,25S,28S,31S,34R)-10-((1H-咪唑-5-基)甲基)-19-((1H-吲哚-3-y基)甲基)-34-((2S,3S)-2-((R)-2-氨基-3-(4-羟基苯基)丙酰胺基)-3-甲基戊酰胺基)-4-(((2S,3S)-1-氨基-3-甲基-1-氧代戊-2-基)(甲基)氨基甲酰基)-25-(3-氨基-3-氧代丙基)-7-(3-胍基丙基)-31-异丙基-13,17-二甲基-28-((1-甲基-1H-吲哚-3-基)甲基)-6,9,12,15,18,21,24,27,30,33-十氧代-1,2-二硫杂-5,8,11,14,17,20,23,26,29,32-十氮杂环三十五烷-22-基)乙酸x三氟乙酸盐(

2-((4R,7S,10S,13S,19S,22S,25S,28S,31S,34R)-10-((1H-咪唑-5-基)甲基)-19-((1H-吲哚-3-y基)甲基)-34-((2S,3S)-2-((R)-2-氨基-3-(4-羟基苯基)丙酰胺基)-3-甲基戊酰胺基)-4-(((2S,3S)-1-氨基-3-甲基-1-氧代戊-2-基)(甲基)氨基甲酰基)-25-(3-氨基-3-氧代丙基)-7-(3-胍基丙基)-31-异丙基-13,17-二甲基-28-((1-甲基-1H-吲哚-3-基)甲基)-6,9,12,15,18,21,24,27,30,33-十氧代-1,2-二硫杂-5,8,11,14,17,20,23,26,29,32-十氮杂环三十五烷-22-基)乙酸x三氟乙酸盐(

2-((4R,7S,10S,13S,19S,22S,25S,28S,31S,34R)-10-((1H-imidazol-5-yl)methyl)-19-((1H-indol-3-yl)methyl)-34-((2S,3S)-2-((R)-2-amino-3-(4-hydroxyphenyl)propanamido)-3-methylpentanamido)-4-(((2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl)(methyl)carbamoyl)-25-(3-amino-3-oxopropyl)-7-(3-guanidinopropyl)-31-isopropyl-13,17-dimethyl-28-((1-methyl-1H-indol-3-yl)methyl)-6,9,12,15,18,21,24,27,30,33-decaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32-decaazacyclopentatriacontan-22-yl)acetic acid x2,2,2-Trifluoroacetic acid salt

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
1mg 95% 询价
- +
5mg 95% 询价
- +
10mg 95% 询价
- +
25mg 95% 询价
- +
50mg 95% 询价
- +
100mg 95% 询价
- +
250mg 95% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

1789738-04-0

中文名称

2-((4R,7S,10S,13S,19S,22S,25S,28S,31S,34R)-10-((1H-咪唑-5-基)甲基)-19-((1H-吲哚-3-y基)甲基)-34-((2S,3S)-2-((R)-2-氨基-3-(4-羟基苯基)丙酰胺基)-3-甲基戊酰胺基)-4-(((2S,3S)-1-氨基-3-甲基-1-氧代戊-2-基)(甲基)氨基甲酰基)-25-(3-氨基-3-氧代丙基)-7-(3-胍基丙基)-31-异丙基-13,17-二甲基-28-((1-甲基-1H-吲哚-3-基)甲基)-6,9,12,15,18,21,24,27,30,33-十氧代-1,2-二硫杂-5,8,11,14,17,20,23,26,29,32-十氮杂环三十五烷-22-基)乙酸x三氟乙酸盐(

英文名称

2-((4R,7S,10S,13S,19S,22S,25S,28S,31S,34R)-10-((1H-imidazol-5-yl)methyl)-19-((1H-indol-3-yl)methyl)-34-((2S,3S)-2-((R)-2-amino-3-(4-hydroxyphenyl)propanamido)-3-methylpentanamido)-4-(((2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl)(methyl)carbamoyl)-25-(3-amino-3-oxopropyl)-7-(3-guanidinopropyl)-31-isopropyl-13,17-dimethyl-28-((1-methyl-1H-indol-3-yl)methyl)-6,9,12,15,18,21,24,27,30,33-decaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32-decaazacyclopentatriacontan-22-yl)acetic acid x2,2,2-Trifluoroacetic acid salt

别名

AMY-101 TFA;Cp40 TFA;2-((4R,7S,10S,13S,19S,22S,25S,28S,31S,34R)-10-((1H-imidazol-5-yl)methyl)-19-((1H-indol-3-yl)methyl)-34-((2S,3S)-2-((R)-2-amino-3-(4-hydroxyphenyl)propanamido)-3-methylpentanamido)-4-(((2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl)(methyl)carbamoyl)-25-(3-amino-3-oxopropyl)-7-(3-guanidinopropyl)-31-isopropyl-13,17-dimethyl-28-((1-methyl-1H-indol-3-yl)methyl)-6,9,12,15,18,21,24,27,30,33-decaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32-decaazacyclopentatriacontan-22-yl)acetic acid x2,2,2-Trifluoroacetic;2-((4R,7S,10S,13S,19S,22S,25S,28S,31S,34R)-10-((1H-imidazol-5-yl)methyl)-19-((1H-indol-3-yl)methyl)-34-((2S,3S)-2-((R)-2-amino-3-(4-hydroxyphenyl)propanamido)-3-methylpentanamido)-4-(((2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl)(methyl)carbamoyl)-25-(3-amino-3-oxopropyl)-7-(3-guanidinopropyl)-31-isopropyl-13,17-dimethyl-28-((1-methyl-1H-indol-3-yl)methyl)-6,9,12,15,18,21,24,27,30,33-decaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32-decaazacyclopentatriacontan-22-yl)acetic acid x2,2,2-Trifluoroacetic acid salt

标准英文名

2,2,2-trifluoroacetic acid--2-((4R,7S,10S,13S,19S,22S,25S,28S,31S,34R)-10-((1H-imidazol-5-yl)methyl)-19-((1H-indol-3-yl)methyl)-34-((2S,3S)-2-((R)-2-amino-3-(4-hydroxyphenyl)propanamido)-3-methylpentanamido)-4-(((2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl)(methyl)carbamoyl)-25-(3-amino-3-oxopropyl)-7-(3-guanidinopropyl)-31-isopropyl-13,17-dimethyl-28-((1-methyl-1H-indol-3-yl)methyl)-6,9,12,15,18,21,24,27,30,33-decaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32-decaazacyclopentatriacontan-22-yl)acetic acid (1/1)

分子式

C85H118F3N23O20S2

分子量

1903.15

精确分子量

1901.83

SMILES

CC[C@H](C)[C@H](NC(=O)[C@H](N)CC1=CC=C(O)C=C1)C(=O)N[C@H]1CSSC[C@@H](C(=O)N(C)[C@H](C(N)=O)[C@@H](C)CC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](C)NC(=O)CN(C)C(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CN(C)C3=C2C=CC=C3)NC(=O)[C@H](C(C)C)NC1=O.O=C(O)C(F)(F)F

标准SMILES

CC(C)[C@@H]1NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](C)NC(=O)CN(C)C(=O)[C@H](CC2=CNC3C=CC=CC2=3)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CN(C)C3C=CC=CC2=3)NC1=O)C(=O)N(C)[C@@H]([C@@H](C)CC)C(N)=O)NC(=O)[C@@H](NC(=O)[C@H](N)CC1=CC=C(O)C=C1)[C@@H](C)CC.OC(=O)C(F)(F)F

用途

AMY-101 TFA (Cp40 TFA) is a peptide inhibitor of complement C3 (KD = 0.5 nM) used for the treatment of naturally occurring chronic periodontitis in non-human primates; it demonstrates potent anti-inflammatory activity in a model of severe COVID-19 pneumonia with systemic hyperinflammation; it significantly and persistently reduces probing pocket depth (PPD), a measure of tissue destruction, following subcutaneous administration (4 mg/kg once daily for 28 days); local injection (0.1 mg/site, 50 μL of 2 mg/mL solution) three times per week or once weekly for 6 weeks improves periodontal conditions without causing irritation in healthy gingiva.

InChIKey

GDSMXERXVAAZHM-HNSVDFJCSA-N

安全信息

SureRoute逆合成路线

1.  1789738-04-0 逆合成路线 1

—
—
ACRIBQ015
1789738-04-0
来源: SureRoute

2.  1789738-04-0 逆合成路线 2

—
—
ACRIBQ015
1789738-04-0
来源: SureRoute

3.  1789738-04-0 逆合成路线 3

—
—
ACRIBQ015
1789738-04-0
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手